Genes related to estrogen action in reproduction and breast cancer

被引:20
作者
Basu, A [1 ]
Rowan, BG [1 ]
机构
[1] Med Coll Ohio, Dept Biochem & Canc Biol, Toledo, OH 43614 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2005年 / 10卷
关键词
estrogen; estrogen receptor; breast cancer; regulated gene; review;
D O I
10.2741/1703
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen is an important steroid hormone with diverse functions in different parts of the human body. The developmental and physiological role of estrogen is mediated by estrogen receptor alpha ( ER-alpha) and newly identified ER-beta. Regulation of expression of various important cellular oncogenes and tumor suppressor genes is a key component of estrogen and ER action. The expression of these genes is crucial in various processes such as cell cycle progression, mammary gland development, growth factor pathways and apoptosis. A very precise and accurate control of these genes is required for normal growth and functioning of cells. Aberrant expression of these genes through elevated expression, gene amplification or mutation may lead to induction and/or progression of different cancers including estrogen-dependent breast cancers. This review briefly describes the role of different genes that are regulated by estrogen in female reproductive tissues and breast cancer.
引用
收藏
页码:2346 / 2372
页数:27
相关论文
共 284 条
[31]   BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer [J].
Bochar, DA ;
Wang, L ;
Beniya, H ;
Kinev, A ;
Xue, YT ;
Lane, WS ;
Wang, WD ;
Kashanchi, F ;
Shiekhattar, R .
CELL, 2000, 102 (02) :257-265
[32]   CYCLIN D1 TRANSGENE IMPEDES LYMPHOCYTE MATURATION AND COLLABORATES IN LYMPHOMAGENESIS WITH THE MYC GENE [J].
BODRUG, SE ;
WARNER, BJ ;
BATH, ML ;
LINDEMAN, GJ ;
HARRIS, AW ;
ADAMS, JM .
EMBO JOURNAL, 1994, 13 (09) :2124-2130
[33]   ESTRADIOL RECEPTORS IN COMBINATION WITH NEU OR MYC ONCOGENE AMPLIFICATIONS MIGHT DEFINE NEW SUBTYPES OF BREAST-CANCER [J].
BOLUFER, P ;
MOLINA, R ;
RUIZ, A ;
HERNANDEZ, M ;
VAZQUEZ, C ;
LLUCH, A .
CLINICA CHIMICA ACTA, 1994, 229 (1-2) :107-122
[34]   Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E [J].
Bowe, DB ;
Kenney, NJ ;
Adereth, Y ;
Maroulakou, IG .
ONCOGENE, 2002, 21 (02) :291-298
[35]   A paracrine role for the epithelial progesterone receptor in mammary gland development [J].
Brisken, C ;
Park, S ;
Vass, T ;
Lydon, JP ;
O'Malley, BW ;
Weinberg, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5076-5081
[36]  
BUCKLEY MF, 1993, ONCOGENE, V8, P2127
[37]  
CARDIFF RD, 1993, CANCER SURV, V16, P97
[38]   IMMUNOHISTOCHEMICAL EVALUATION OF ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT IN 183 PATIENTS WITH ENDOMETRIAL CARCINOMA .2. CORRELATION BETWEEN BIOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS AND SURVIVAL [J].
CHAMBERS, JT ;
CARCANGIU, ML ;
VOYNICK, IM ;
SCHWARTZ, PE .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (03) :255-260
[39]   Germline BRCA1/2 mutations and p27Kip1 protein levels independently predict outcome after breast cancer [J].
Chappuis, PO ;
Kapusta, L ;
Bégin, LR ;
Wong, N ;
Brunet, JS ;
Narod, SA ;
Slingerland, J ;
Foulkes, WD .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) :4045-4052
[40]   Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix [J].
Cheung, TH ;
Yu, MMY ;
Lo, KWK ;
Yim, SF ;
Chung, TKH ;
Wong, YF .
CANCER LETTERS, 2001, 166 (02) :199-206